Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study
Guolan Lu, Nynke S. van den Berg, Brock A. Martin, Naoki Nishio, Zachary Hart, Stan van Keulen, Shayan Fakurnejad, Stefania U. Chirita, Roan C. Raymundo, Grace Yi, Quan Zhou, George A. Fisher, Eben L. Rosenthal, George A. Poultsides
Topics & Concepts
MedicinePanitumumabClinical endpointPancreatic cancerBiopsyCapecitabineSurgeryInternal medicineCancerResponse Evaluation Criteria in Solid TumorsPhases of clinical researchOncologyGastroenterologyCetuximabChemotherapyColorectal cancerClinical trialCancer Research and TreatmentsNanoplatforms for cancer theranosticsPancreatic and Hepatic Oncology Research